WHO ICTRP trial
Does taking the drug thyroxine on an empty stomach or with food significantly…
ACTRN12609000032257 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12609000032257 |
|---|---|
| Public title | Does taking the drug thyroxine on an empty stomach or with food significantly alter its absorption in treating patients with hypothyroidism? |
| Scientific title | Does taking the drug thyroxine on an empty stomach or with food significantly alter its absorption in treating patients with hypothyroidism? |
| Primary sponsor | Associate Professor Dr Patrick Manning |
| Secondary sponsors | Ahrin Anna Choi |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | New Zealand |
| Conditions | Absorption of the drug thyroxine in patients with hypothyroidism; Absorption of the drug thyroxine in patients with hypothyroidism;Metabolic and Endocrine - Thyroid disease |
| Interventions | Participants who are taking a standard oral dose of the thyroxine tablet manufactured by GlaxoSmithKline (brand name: Eltroxin) will take their thyroxine tablet orally with food (their meal). Their dosage amount will continue to be what has… |
| Registration date | Jan 19, 2009 |
| Target size | 40 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: